跳至主要内容
临床试验/NCT01734551
NCT01734551已完成4 期

Pharmacological Treatment of Neonatal Abstinence Syndrome: Opiate Versus Non-Opiate

Henrietta Bada1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
31
试验地点
1
主要终点
Finnegan Neonatal Abstinence Scoring System

研究概览

简要总结

The purpose of this study is to compare two different medicines to treat babies with opiate withdrawal. The treatment medicines are morphine, which is an opiate, and clonidine, a non-opiate. Morphine is a narcotic medicine, with is included in most pain killers. Clonidine is another drug, but is different from morphine. It is also used for babies, and even adults for withdrawal symptoms. Both drugs are effective, but the purpose of this study is to see if one may be better than the other.

详细描述

Withdrawal from drugs, called Neonatal abstinence syndrome (NAS), is a group of symptoms that occurs to babies whose mother took or used drugs (prescription, addicting, illegal, pain pills, or drugs for addiction treatment) during pregnancy. Medicines the mother takes while pregnant, the baby also takes. Babies may experience withdrawal after delivery, and may need treatment. There are different ways to treat babies with withdrawal - about 50% of doctors use morphine, an opiate, to treat these babies, the rest uses other drugs, like clonidine and phenobarbitol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Day 至 7 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Admitted to Neonatal Intensive Care Unit (NICU)- Gestational age (GA) >or= 35 wks
  • Known prenatal opiate exposure (maternal history, positive opiate screen, positive neonatal urine or meconium screen)
  • Symptomatic with Finnegan Neonatal Abstinence Scores meeting NICU protocol for treatment

排除标准

  • Major congenital malformations
  • Unlikely to survive
  • Parents not able to understand English

研究组 & 干预措施

Morphine

Active Comparator

Initial dose is 0.4mg/kg/day, divided every 3-4 hours, given PO with feeds. Drug is required until symptoms of withdrawal no longer cause the infant feeding, behavior, or elimination problems, up to 3 months.

干预措施: Morphine (Drug)

Clonidine

Active Comparator

Dose is started at 5 mcg/kg/day, given PO with feeds, divided every 3-4 hours. Drug is required until symptoms of withdrawal no longer cause the infant feeding, behavior, or elimination problems, up to 3 months.

干预措施: Clonidine (Drug)

结局指标

主要结局

Finnegan Neonatal Abstinence Scoring System

时间窗: 14 days

Mean of total Finnegan Scores obtained every 3 hours on days 2, 7, and 14 following start of treatment; A score is a number representing the total score or sum from 21 items or symptoms or manifestations of opiate withdrawal in newborn infants. The total score ranges from 0 to 43. Reference: 1. Finnegan LP, Connaughton JF, Jr., Kron RE, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975;2(1-2):141-58. Although normal newborn may manifest mild symptoms that will give scores in the range of 0 to 7. A score of 8 consecutively obtained times 3 indicate that infant will benefit from treatment, in this study morphine or clonidine. A decrease in scores especially to less than 8 is suggestive of a good response to treatment.

Duration of Treatment

时间窗: 120 days

Total number days of treatment

次要结局

  • Neurobehavioral Performance Summary Scores From the Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS)(5-10 days after treatment starts)
  • Bayley Scales of Infant and Toddler Development Third Edition(1 year of life)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Henrietta Bada

PI

University of Kentucky

研究点 (1)

Loading locations...

相似试验